Literature DB >> 1001248

Inhibition of ovarian estradiol-17beta secretion by luteinizing hormone in prepubertal, pregnant mare serum-treated rats.

Y Katz, D T Armstrong.   

Abstract

Serum estradiol-17beta levels, elevated prior to the luteinizing hormone (LH) surge, decline abruptly following the release of endogenous LH or the injection of exogenous LH. To investigate the mechanism of this decline, bovine LH (NIH-LH-B8) was administered to immature rats, in which follicular maturation and estrogen biosynthesis were induced by a non-ovulating dose of pregnant mare serum gonadotropin (PMS). Serum and ovarian estradiol-17beta concentrations fell detectably by 4h, and reached levels around 20% of the controls by 8h after iv injection of 10 mug LH. Concomitant decreases occurred in ovarian androgen concentrations, following an initial rise, and in the in vitro ovarian testosterone aromatizing enzyme activity. The LH-induced inhibition of the aromatase activity was found to be of a non-competitive type. It is proposed that two enzyme systems are inhibited as a result of the LH treatment: the C17,20-lyase and the C19 androgen aromatase, thereby leading to decreased concentrations of estrogens in the ovaries and blood.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001248     DOI: 10.1210/endo-99-6-1442

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  The Involvement of Granulosa Cells in the Regulation by Gonadotropins of Cyp17a1 in Theca Cells.

Authors:  Hanako Kakuta; Taisen Iguchi; Tomomi Sato
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

2.  When Electrospun Fiber Support Matters: In Vitro Ovine Long-Term Folliculogenesis on Poly (Epsilon Caprolactone) (PCL)-Patterned Fibers.

Authors:  Chiara Di Berardino; Liliana Liverani; Alessia Peserico; Giulia Capacchietti; Valentina Russo; Nicola Bernabò; Umberto Tosi; Aldo Roberto Boccaccini; Barbara Barboni
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.